Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

St. Vincent's Screening To Prevent Heart Failure (STOP-HF) Study Using Natriuretic Peptides to Identify and Prevent Progression of Left Ventricular Dysfunction in Community Based, Asymptomatic, At-risk Individuals.

NCT00921960 is registered in ClinicalTrials.gov with St Vincent's University Hospital, Ireland as lead sponsor.

NCT NCT00921960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00921960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
St. Vincent's Screening To Prevent Heart Failure (STOP-HF) Study Using Natriuretic Peptides to Identify and Prevent Progression of Left Ventricular Dysfunction in Community Based, Asymptomatic, At-risk Individuals.
Lead sponsor
St Vincent's University Hospital, Ireland
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2005
Completion date
December 31, 2017
Enrollment
1,378 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hypertension, left ventricular dysfunction, myocardial infarction, obesity